Literature DB >> 4467160

The pharmacokinetics of clotrimazole 14C.

B Duhm, H Medenwald, J Puetter, W Maul, K Patzschke, L A Wegner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4467160

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.

Authors:  M J Humphrey; S Jevons; M H Tarbit
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

2.  Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

Authors:  T Tiffert; H Ginsburg; M Krugliak; B C Elford; V L Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 3.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

4.  Experimental infection of goats and guinea pigs with Microsporum canis and trials on treatment with canesten cream and neguvon solution.

Authors:  M T Abu-Samra; B E Hago
Journal:  Mycopathologia       Date:  1980-10-31       Impact factor: 2.574

5.  Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.

Authors:  C Brugnara; B Gee; C C Armsby; S Kurth; M Sakamoto; N Rifai; S L Alper; O S Platt
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

6.  Electrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration Therapy.

Authors:  Willem S Lexmond; Paul A Rufo; Edda Fiebiger; Wayne I Lencer
Journal:  PLoS Negl Trop Dis       Date:  2015-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.